Neuland Laboratories' Stock Reaches All-Time High, Outperforms Sector by 8.32%
Neuland Laboratories, a midcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs. 15475 on October 15, 2024. The stock has outperformed the sector by 8.32% and has consistently traded above its moving averages. With a strong performance of 294.31% in the past year, the company shows potential for growth in the pharmaceutical industry.
Neuland Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its recent surge in stock price. On October 15, 2024, the company's stock reached a 52-week high of Rs. 15475, which is also an all-time high for the company. This has caught the attention of investors and analysts, with MarketsMOJO giving a 'Buy' call for the stock.
The stock has shown strong performance today, outperforming the sector by 8.32%. It opened with a gap up of 2.82% and reached an intraday high of Rs. 15475, showing a high volatility of 6.48%. This is calculated from the weighted average price, indicating a significant movement in the stock.
Neuland Laboratories has also been consistently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for the company's stock.
In the past year, Neuland Laboratories has shown an impressive performance of 294.31%, while the Sensex has only grown by 23.36%. This shows the company's strong potential and growth in the pharmaceutical industry.
With its recent surge in stock price and positive performance, Neuland Laboratories is definitely a company to watch out for in the midcap pharmaceutical sector. Investors can consider adding this stock to their portfolio for potential growth and returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
